A research article to be published on September 7, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Zheng from Zhengzhou University used fluorescence real-time quantitative PCR to study the levels of mRNA expression of hefA in MDR strains and its parent strains. To futher evaluate the contribution of hefA in multidrug resistance of H pylori, the article also constructed an H pylori mutant strain (△H. pylori LZ1026), and detected the susceptibility to 10 antimicrobials of the △H pylori LZ1026 with a more sensitive method of twofold agar dilution tests.

Six multidrug-resistant strains (including 5 clinical isolates and H pylori NCTC11637) were selected, and their MICs showed a significant (≥ 4-fold) increase than their parent strains. The expression levels of hefA gene in the MDR strains were significantly higher compared with their parent strains (P = 0.033). An H pylori LZ1026 mutant was successfully constructed and the △H pylori LZ1026 was more susceptible to four of the 10 antibiotics. All 20 strains displayed transcripts for hefA that confirmed the in vitro expression of these genes.

The results revealed that the relative expression of hefA in the induced multidrug resistant strains were higher than those in their wild susceptible isolates. It has shown that similar to other gram-negative organisms, the H pylori hefA mutant displayed increased susceptibilities to antibiotics. It confirmed that high expression of the hefA plays an important role in multidrug-resistance of H pylori. H pylori contains an active multidrug efflux mechanism and therefore compound efflux needs to be taken into account when determining resistance mechanisms in this organism.

Source: World Journal of Gastroenterology